Victory Capital Management’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-24,843
Closed -$983K 2418
2025
Q4
$983K Buy
+24,843
New +$911K ﹤0.01% 1843
2025
Q2
Sell
-57,239
Closed -$1.85M 2482
2025
Q1
$1.85M Buy
+57,239
New +$2.12M ﹤0.01% 1553
2024
Q1
Sell
-6,202
Closed -$221K 2485
2023
Q4
$221K Buy
6,202
+1,155
+23% +$43K ﹤0.01% 2205
2023
Q3
$221K Buy
5,047
+106
+2% +$5.17K ﹤0.01% 2187
2023
Q2
$244K Sell
4,941
-3,527
-42% -$163K ﹤0.01% 2161
2023
Q1
$351K Sell
8,468
-4,020
-32% -$167K ﹤0.01% 2100
2022
Q4
$554K Buy
12,488
+5,955
+91% +$249K ﹤0.01% 1979
2022
Q3
$255K Sell
6,533
-5,399
-45% -$247K ﹤0.01% 2296
2022
Q2
$488K Sell
11,932
-5,112
-30% -$242K ﹤0.01% 2062
2022
Q1
$885K Sell
17,044
-295
-2% -$19.1K ﹤0.01% 1869
2021
Q4
$1.21M Sell
17,339
-664
-4% -$48.3K ﹤0.01% 1755
2021
Q3
$1.25M Sell
18,003
-1,185
-6% -$91.2K ﹤0.01% 1760
2021
Q2
$1.52M Buy
19,188
+5,204
+37% +$378K ﹤0.01% 1715
2021
Q1
$916K Sell
13,984
-1,346
-9% -$82.9K ﹤0.01% 1958
2020
Q4
$853K Sell
15,330
-5,831
-28% -$252K ﹤0.01% 1855
2020
Q3
$844K Buy
21,161
+58
+0.3% +$2.46K ﹤0.01% 1780
2020
Q2
$949K Buy
21,103
+7,682
+57% +$334K ﹤0.01% 1752
2020
Q1
$451K Sell
13,421
-2,100
-14% -$75.5K ﹤0.01% 1878
2019
Q4
$505K Buy
15,521
+2,713
+21% +$77.2K ﹤0.01% 2007
2019
Q3
$319K Buy
12,808
+9,650
+306% +$276K ﹤0.01% 2054
2019
Q2
$94K Hold
3,158
﹤0.01% 1636
2019
Q1
$85K Hold
3,158
﹤0.01% 1670
2018
Q4
$97K Sell
3,158
-601
-16% -$18.7K ﹤0.01% 1644
2018
Q3
$132K Buy
3,759
+494
+15% +$15.6K ﹤0.01% 1643
2018
Q2
$88K Hold
3,265
﹤0.01% 1716
2018
Q1
$67K Sell
3,265
-1,065,630
-100% -$19.2M ﹤0.01% 1733
2017
Q4
$19.5M Buy
1,068,895
+40,550
+4% +$803K 0.04% 586
2017
Q3
$23M Sell
1,028,345
-291,130
-22% -$6.58M 0.05% 541
2017
Q2
$32M Buy
1,319,475
+18,536
+1% +$394K 0.07% 436
2017
Q1
$24.9M Sell
1,300,939
-27,739
-2% -$486K 0.06% 523
2016
Q4
$26M Buy
1,328,678
+65,898
+5% +$1.19M 0.07% 496
2016
Q3
$20M Buy
1,262,780
+1,210,450
+2,313% +$18.6M 0.06% 556
2016
Q2
$739K Buy
52,330
+110
+0.2% +$1.68K ﹤0.01% 910
2016
Q1
$879K Buy
52,220
+573
+1% +$10.1K ﹤0.01% 843
2015
Q4
$1.16M Buy
51,647
+6,845
+15% +$141K ﹤0.01% 751
2015
Q3
$982K Sell
44,802
-1,696
-4% -$42.4K ﹤0.01% 721
2015
Q2
$1.15M Buy
46,498
+2,181
+5% +$48.7K ﹤0.01% 717
2015
Q1
$908K Sell
44,317
-1,600
-3% -$31K ﹤0.01% 659
2014
Q4
$917K Buy
+45,917
New +$788K ﹤0.01% 686

Other funds holding ATRC

Victory Capital Management's ATRC Position: Q1 2026 in Review

Victory Capital Management sold out of AtriCure (ATRC) in Q1 2026, closing a stake of 24,843 shares — an estimated $983K sold.

Victory Capital Management first reported a position in ATRC in Q4 2014 and held it in 39 quarters. The position peaked at $32M in Q2 2017. 224 funds tracked by Wall St. Rank hold ATRC as of Q1 2026.

  • Victory Capital Management reported no remaining AtriCure position as of Q1 2026 after selling out during the quarter.
  • Victory Capital Management sold 24,843 AtriCure shares in Q1 2026, an estimated $983K.
  • Victory Capital Management first reported a position in AtriCure in Q4 2014 and held it in 39 quarters.
  • Victory Capital Management's AtriCure position peaked at $32M in Q2 2017.
  • 224 funds tracked by Wall St. Rank held AtriCure as of Q1 2026.

Based on Victory Capital Management's 13F filing for Q1 2026, filed 15 May 2026.